Ledger.Open graph →
SEC Form D · filed December 24, 2014

Novira Therapeutics, Inc

Offering
$9.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DOYLESTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Nathaniel M. Brown · Doylestown, PAExecChristian S. Schade · Doylestown, PAExec · DirectorDouglas S. Carr · Doylestown, PAExecGianni M. Gromo · San Francisco, CADirectorTim M. Shannon · Westport, CTDirectorGreg C. Lee · Fayetteville, ARExecChristian S. Schade · Doylestown, PAExec · DirectorGianni M. Gromo · San Francisco, CADirectorKlaus M. Klumpp · Doylestown, PAExecKlaus M. Klumpp · Doylestown, PAExecHoward S. Garfield · Addison, TXDirectorDouglas S. Carr · Doylestown, PAExecScott M. Rocklage · Menlo Park, CADirectorRon C. Foster · Fayetteville, ARExecAnthony M. Ford-Hutchinson · Doylestown, PADirectorRobert T. Poynter · Addison, TXDirectorScott M. Rocklage · Menlo Park, CADirectorOsvaldo S. Flores · Doylestown, PAExecNathaniel M. Brown · Doylestown, PAExecGeorge M. Hartman · Doylestown, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗